U.S. Neurosurgical Holdings, Inc.
USNU
$0.8854
$0.00180.20%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 115.50% | 66.28% | 33.01% | -28.14% | -36.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.50% | 66.28% | 33.01% | -28.14% | -36.13% |
| Operating Income | -115.50% | -66.28% | -33.01% | 28.14% | 36.13% |
| Income Before Tax | -687.18% | -184.07% | -0.17% | 46.60% | 93.85% |
| Income Tax Expenses | -540.54% | -528.95% | -517.95% | -- | 148.68% |
| Earnings from Continuing Operations | -451.81% | -119.71% | 16.65% | 47.99% | 92.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -506.90% | -250.79% | -110.00% | -99.57% | -93.05% |
| Net Income | -621.34% | -184.92% | 0.20% | 38.91% | 91.97% |
| EBIT | -115.50% | -66.28% | -33.01% | 28.14% | 36.13% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -298.16% | -82.48% | 18.48% | 44.62% | 91.72% |
| Normalized Basic EPS | -527.92% | -4,380.00% | -60.99% | 16.30% | 110.27% |
| EPS Diluted | -298.16% | -82.48% | 18.48% | 44.62% | 91.72% |
| Normalized Diluted EPS | -527.92% | -4,380.00% | -60.99% | 16.30% | 110.27% |
| Average Basic Shares Outstanding | 76.65% | 48.29% | 30.96% | 18.24% | 1.44% |
| Average Diluted Shares Outstanding | 76.65% | 48.29% | 30.96% | 18.24% | 1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
